» Articles » PMID: 20663029

Potential of the Bioflavonoids in the Prevention/treatment of Ocular Disorders

Overview
Specialties Pharmacology
Pharmacy
Date 2010 Jul 29
PMID 20663029
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Flavonoids are a common group of plant polyphenols that give colour and flavour to fruits and vegetables. In recent years, flavonoids have gained importance in the pharmaceutical field through their beneficial effects on human health and are widely available as nutritional supplements. Several pharmacological actions of the bioflavonoids may be useful in the prevention or treatment of ocular diseases responsible for vision loss such as diabetic retinopathy, macular degeneration and cataract. This review aims to summarize the potential therapeutic applications of various bioflavonoids in different ocular diseases and also discusses delivery of these agents to the ocular tissues.

Key Findings: It is apparent that the flavonoids are capable of acting on various mechanisms or aetiological factors responsible for the development of different sight threatening ocular diseases. From a drug delivery perspective, ocular bioavailability depends on the physicochemical and biopharmaceutical characteristics of the selected flavonoids and very importantly the route of administration.

Summary: The potential therapeutic applications of various bioflavonoids in ocular diseases is reviewed and the delivery of these agents to the ocular tissues is discussed. Whereas oral administration of bioflavonoids may demonstrate some pharmacological activity in the outer sections of the posterior ocular segment, protection of the retinal ganglionic cells in vivo may be limited by this delivery route. Systemic or local administration of these agents may yield much higher and effective concentrations of the parent bioflavonoids in the ocular tissues and at much lower doses.

Citing Articles

The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.

DAngelo A, Lixi F, Vitiello L, Gagliardi V, Pellegrino A, Giannaccare G Biomed Res Int. 2025; 2025:6654976.

PMID: 40041571 PMC: 11876532. DOI: 10.1155/bmri/6654976.


Systems pharmacology dissection of the mechanisms and therapeutic potential of Cassiae semen for hepatoprotection and brightening eyes.

Zhang J, Chen Z, Huang X, Qi L, Zhou W J Food Drug Anal. 2024; 30(3):417-426.

PMID: 39666297 PMC: 9635915. DOI: 10.38212/2224-6614.3417.


Effect of High-Sucrose Diet on the Occurrence and Progression of Diabetic Retinopathy and Dietary Modification Strategies.

Yang C, Yu Y, An J Nutrients. 2024; 16(9).

PMID: 38732638 PMC: 11085904. DOI: 10.3390/nu16091393.


Targeting inflammation and oxidative stress for protection against ischemic brain injury in rats using cupressuflavone.

Albaqami F, Abdel-Rahman R, Althurwi H, Alharthy K, Soliman G, Aljarba T Saudi Pharm J. 2024; 32(1):101933.

PMID: 38204594 PMC: 10777008. DOI: 10.1016/j.jsps.2023.101933.


PLGA Nanoparticles Containing Natural Flavanones for Ocular Inflammation.

Bustos-Salgado P, Dominguez-Villegas V, Andrade-Carrera B, Mallandrich M, Calpena A, Domenech O Pharmaceutics. 2023; 15(12).

PMID: 38140093 PMC: 10748021. DOI: 10.3390/pharmaceutics15122752.


References
1.
Kim S, Kwak J, Shin J, Lee S . The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina. Ophthalmologica. 1998; 212(4):268-74. DOI: 10.1159/000027305. View

2.
Cornish K, Williamson G, Sanderson J . Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med. 2002; 33(1):63-70. DOI: 10.1016/s0891-5849(02)00843-2. View

3.
Shiratori K, Ohgami K, Ilieva I, Jin X, Yoshida K, Kase S . The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther. 2005; 21(4):298-304. DOI: 10.1089/jop.2005.21.298. View

4.
Steigerwalt R, Gianni B, Paolo M, Bombardelli E, Burki C, Schonlau F . Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mol Vis. 2008; 14:1288-92. PMC: 2447819. View

5.
Zhang B, Safa R, Rusciano D, Osborne N . Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res. 2007; 1159:40-53. DOI: 10.1016/j.brainres.2007.05.029. View